M&A Deal Summary

Teligent Acquires Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection

On October 5, 2015, Teligent acquired life science company Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection from ADVANZ PHARMA for 10M USD

Acquisition Highlights
  • This is Teligent’s 1st transaction in the Life Science sector.
  • This is Teligent’s 2nd largest (disclosed) transaction.
  • This is Teligent’s 1st transaction in Canada.
  • This is Teligent’s 1st transaction in Ontario.

M&A Deal Summary
Date 2015-10-05
Target Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection
Sector Life Science
Buyer(s) Teligent
Sellers(s) ADVANZ PHARMA
Deal Type Divestiture
Deal Value 10M USD

Target

Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection

Oakville, Ontario, Canada
Fortaz®, ZinacefTM, and Zantac® Injection are the products used in specialty generic pharma.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teligent

Buena, New Jersey, United States
Category Company
Founded 1977
Sector Life Science
Employees252
Revenue 66M USD (2019)
DESCRIPTION

Teligent manufactures, fills and packages topical semi?solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers. Teligent’s products are used for cosmetic, cosmeceutical and prescription applications for the treatment of symptoms of dermatitis, acne, psoriasis, and eczema. Teligent was founded in 1977 and is based in Buena, New Jersey.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ontario) 1 of 2
Country (Canada) 1 of 2
Year (2015) 1 of 2
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-16 Alveda Pharmaceuticals

Toronto, Ontario, Canada

Alveda Pharmaceuticals, Inc. is specializing in the sale and distribution of quality pharmaceuticals. Alveda Pharmaceuticals was founded in Toronto, Ontario.

Buy CA$47M

Seller(S) 1

SELLER

ADVANZ PHARMA

London, United Kingdom
Category Company
Founded 1963
Sector Life Science
Employees675
Revenue 508M USD (2019)
DESCRIPTION

ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines with direct sales access in Europe and a global distribution network. ADVANZ PHARMA was founded in 1963 and is based in London, United Kingdom.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-08 Amdipharm Mercury - AMCo.

Croydon, United Kingdom

Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.

Buy $3.5B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-04-01 Eisai - Two Medicines

Woodcliff Lake, New Jersey, United States

Eisai, Inc. - Two Medicines (Salagen & Panretin) is a pharmaceutical business, Salagen® indications include the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck, and the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome. Panretin® indications include the topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma (KS).

Buy $33M
Mergr

Product

Company

Legal